FACTORS ASSOCIATED WITH TIME TO DISABILITY PROGRESSION IN PATIENTS WITH MULTIPLE SCLEROSIS

被引:2
作者
Arteaga-Noriega, Anibal [1 ,2 ]
Castro-Alvarez, John Fredy [3 ]
Benjumea-Bedoya, Dione [2 ]
Gutierrez-Vargas, Johanna [3 ]
Segura-Cardona, Angela [1 ]
Gonzalez-Gomez, Difariney [4 ]
Zapata-Berruecos, Jose [1 ,5 ]
机构
[1] Univ CES, Epidemiol & Biostat Res Grp, Medellin, Colombia
[2] Remington Univ Corp, Family & Community Hlth Res Grp, Medellin, Colombia
[3] Remington Univ Corp, Neurosci & Aging Res Grp, Medellin, Colombia
[4] Univ Antioquia, Natl Sch Publ Hlth, Medellin, Colombia
[5] Neurol Inst Colombia, Medellin, Colombia
来源
REVISTA PERUANA DE MEDICINA EXPERIMENTAL Y SALUD PUBLICA | 2022年 / 39卷 / 04期
关键词
multiple sclerosis; Multivariate Analysis; disability evaluations; CEREBELLAR CORTEX; DEMYELINATION; DIAGNOSIS;
D O I
10.17843/rpmesp.2022.394.11433
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. To determine the sociodemographic, clinical and radiological factors associated with time to disability progression in patients with multiple sclerosis (MS). Materials and methods. Cross-sectional descriptive study with an analytical component, based on clinical records of patients at the Neurological Institute of Colombia, between 2013 and 2021. Progression to disability in MS patients was defined as the time to an increase of at least 0.5 points in the EDSS (Expanded Disability Status Scale) score, sustained for at least six months. A Cox regression model was used to estimate the survival function and Hazard Ratios (HR) with their 95% confidence intervals (95% CI). Results. We included 216 patients, of whom 25% progressed to disability, median survival was 78 months (95% CI: 70-83), active lesions (HR = 1.94; 95% CI: 1.10-3.44), cerebellar complications (HR = 2.03; 95% CI: 0. 99-4.16), being male (HR = 2.5; 95% CI: 1.32-4.73), and having neurological diseases (HR = 2.18; 95% CI: 1.03-4.61) were associated as risk factors. While relapsing remitting MS (HR = 0.63; 95% CI: 0.31-1.26) and age at diagnosis less than 40 years (HR = 0.96; 95% CI: 0.53-1.76) were associated as protective factors. . Conclusions. Progression is affected by many factors, and there is no single independent factor.
引用
收藏
页码:442 / 449
页数:8
相关论文
共 30 条
  • [1] Diagnosis of multiple sclerosis: progress and challenges
    Brownlee, Wallace J.
    Hardy, Todd A.
    Fazekas, Franz
    Miller, David H.
    [J]. LANCET, 2017, 389 (10076) : 1336 - 1346
  • [2] Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes
    Ciampi, Ethel
    Uribe-San-Martin, Reinaldo
    Soler, Bernardita
    Molnar, Karolyn
    Reyes, Diego
    Keller, Karina
    Carcamo, Claudia
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [3] COURSE AND PROGNOSIS OF MULTIPLE-SCLEROSIS ASSESSED BY THE COMPUTERIZED DATA-PROCESSING OF 349 PATIENTS
    CONFAVREUX, C
    AIMARD, G
    DEVIC, M
    [J]. BRAIN, 1980, 103 (JUN) : 281 - 300
  • [4] Natural history of multiple sclerosis in a population-based cohort
    Debouverie, M.
    Pittion-Vouyovitch, S.
    Louis, S.
    Guillemin, F.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (09) : 916 - 921
  • [5] Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
    Dekker, I
    Leurs, C. E.
    Hagens, M. H. J.
    van Kempen, Z. L. E.
    Kleerekooper, I
    Lissenberg-Witte, B., I
    Barkhof, F.
    Uitdehaag, B. M. J.
    Balk, L. J.
    Wattjes, M. P.
    Killestein, J.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 82 - 87
  • [6] Immunopathology of multiple sclerosis
    Dendrou, Calliope A.
    Fugger, Lars
    Friese, Manuel A.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2015, 15 (09) : 545 - 558
  • [7] Deep gray matter volume loss drives disability worsening in multiple sclerosis
    Eshaghi, Arman
    Prados, Ferran
    Brownlee, Wallace J.
    Altmann, Daniel R.
    Tur, Carmen
    Cardoso, M. Jorge
    De Angelis, Floriana
    van de Pavert, Steven H.
    Cawley, Niamh
    De Stefano, Nicola
    Stromillo, M. Laura
    Battaglini, Marco
    Ruggieri, Serena
    Gasperini, Claudio
    Filippi, Massimo
    Rocca, Maria A.
    Rovira, Alex
    Sastre-Garriga, Jaume
    Vrenken, Hugo
    Leurs, Cyra E.
    Killestein, Joep
    Pirpamer, Lukas
    Enzinger, Christian
    Ourselin, Sebastien
    Wheeler-Kingshott, Claudia A. M. Gandini
    Chard, Declan
    Thompson, Alan J.
    Alexander, Daniel C.
    Barkhof, Frederik
    Ciccarelli, Olga
    [J]. ANNALS OF NEUROLOGY, 2018, 83 (02) : 210 - 222
  • [8] Federacion Internacional de Esclerosis Multiple, 2020, Atlas de Esclerosis Multiple tercera edicion, V3ra
  • [9] Multiple Sclerosis
    Files, Daniel Kane
    Jausurawong, Tani
    Katrajian, Ruba
    Danoff, Robert
    [J]. PRIMARY CARE, 2015, 42 (02): : 159 - +
  • [10] Filippi M, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/s41572-018-0046-z, 10.1038/s41572-018-0041-4]